Fritextsökning
Artiklar per år
Innehållstyper
-
Novozymes till Nebraska
Danmarks kronprinspar var på plats när det första spadtaget till den nya enzym- och etanolfabriken togs.
-
Ny och vassare mjukvara från CLC Bio
Danska CLC Bio har byggt ut sin mjukvaruplattform för genomisk analys med nytt stöd för både mikroarraybaserade och digitala genuttrycksmätningar samt extra snabba nya algoritmer för högprestandasekvenseringsdata. Dessutom finns en ny serverlösning för att effektivisera arbetet i forskningsorganisationer.
-
Mot börsen med kassan full
Det norska cancerforskningsföretaget Algeta tar in 35 miljoner US-dollar för att fortsätta utvecklingen av sitt mest lovande cancerprojekt.
-
Danskt stöd för ESS till Lund
Stödet växer för att den nya superforskningsanläggningen ska hamna i Lund. Den danska Läkemedelsindustriföreningen ställer sig nu bakom försöken att få ESS till Sverige. Tre kandidater tävlar om miljardsatsningen.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Sales Representative, Applied Biosystems
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a significant difference for their sister clusters.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.